Clinical trials
Stroke trials in Nigeria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt University Medical Center | 6 |
| Bayero University Kano, Nigeria | 2 |
| The George Institute | 2 |
| University of California, Los Angeles | 2 |
| Babcock University | 1 |
| Barau Dikko Teaching Hospital | 1 |
| Medical University of South Carolina | 1 |
| National Assembly Clinic | 1 |
| Northern California Institute of Research and Education | 1 |
| Population Health Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 20 |
| Anemia, Sickle Cell | 7 |
| Ischemic Stroke | 3 |
| Hemorrhagic Stroke | 2 |
| Hypertension | 2 |
| Atrial Fibrillation | 1 |
| Cerebral Hemorrhage | 1 |
| Eclampsia | 1 |
| Neurologic Manifestations | 1 |
| Pre-Eclampsia | 1 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.